AC Immune Statistics

Total Valuation

AC Immune has a market cap or net worth of $295.83 million. The enterprise value is $104.54 million.

Market Cap	295.83M
Enterprise Value	104.54M

Important Dates

The next estimated earnings date is Friday, November 1, 2024, before market open.

Earnings Date	Nov 1, 2024
Ex-Dividend Date	n/a

Share Statistics

AC Immune has 98.94 million shares outstanding. The number of shares has increased by 10.73% in one year.

Shares Outstanding	98.94M
Shares Change (YoY)	+10.73%
Shares Change (QoQ)	+0.17%
Owned by Insiders (%)	4.88%
Owned by Institutions (%)	10.17%
Float	40.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	16.06
Forward PS	35.75
PB Ratio	2.17
P/FCF Ratio	5.69
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	6.07
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	2.01

Financial Position

The company has a current ratio of 1.80, with a Debt / Equity ratio of 0.03.

Current Ratio	1.80
Quick Ratio	1.76
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	0.07
Interest Coverage	-492.10

Financial Efficiency

Return on equity (ROE) is -46.06% and return on invested capital (ROIC) is -27.95%.

Return on Equity (ROE)	-46.06%
Return on Assets (ROA)	-19.06%
Return on Capital (ROIC)	-27.95%
Revenue Per Employee	$107,054
Profits Per Employee	-$418,242
Employee Count	161
Asset Turnover	0.08
Inventory Turnover	n/a

Taxes

In the past 12 months, AC Immune has paid $4,451 in taxes.

Income Tax	4,451
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.39% in the last 52 weeks. The beta is 1.24, so AC Immune's price volatility has been higher than the market average.

Beta (5Y)	1.24
52-Week Price Change	-9.39%
50-Day Moving Average	3.52
200-Day Moving Average	3.50
Relative Strength Index (RSI)	37.43
Average Volume (20 Days)	87,298

Short Selling Information

Short Interest	783,974
Short Previous Month	938,339
Short % of Shares Out	1.48%
Short % of Float	n/a
Short Ratio (days to cover)	4.46

Income Statement

In the last 12 months, AC Immune had revenue of $17.24 million and -$67.34 million in losses. Loss per share was -$0.73.

Revenue	17.24M
Gross Profit	-48.82M
Operating Income	-66.81M
Pretax Income	-69.76M
Net Income	-67.34M
EBITDA	-65.03M
EBIT	-66.81M
Loss Per Share	-$0.73

Full Income Statement

Balance Sheet

The company has $194.89 million in cash and $3.59 million in debt, giving a net cash position of $191.29 million or $1.93 per share.

Cash & Cash Equivalents	194.89M
Total Debt	3.59M
Net Cash	191.29M
Net Cash Per Share	$1.93
Equity (Book Value)	137.35M
Book Value Per Share	1.38
Working Capital	89.04M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $49.59 million and capital expenditures -$849,099, giving a free cash flow of $51.98 million.

Operating Cash Flow	49.59M
Capital Expenditures	-849,099
Free Cash Flow	51.98M
FCF Per Share	$0.53

Full Cash Flow Statement

Margins

Gross Margin	-283.23%
Operating Margin	-387.63%
Pretax Margin	-390.66%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	286.56%

Dividends & Yields

AC Immune does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.73%
Shareholder Yield	-10.73%
Earnings Yield	-22.76%
FCF Yield	17.57%

Analyst Forecast

The average price target for AC Immune is $12.00, which is 301.34% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$12.00
Price Target Difference	301.34%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	49.47%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AC Immune has an Altman Z-Score of -1.11 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.11
Piotroski F-Score	4